Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment

Higher Treg levels are associated with favorable tumor stage. We hypothesize that a dramatic decrease of Treg after in vivo irradiation may be a good indicator for necessary dose adjustments in radiation therapy of CRC patients.